Insights

Innovative Drug Delivery BDD specializes in controlled and delayed-release oral formulations using proprietary OralogiK technology, presenting ample opportunity to collaborate with pharmaceutical companies seeking advanced drug release solutions, especially for targeted therapies.

Expansion of Clinical Capabilities With comprehensive clinical services including protocol development, regulatory submissions, and gamma scintigraphy technology, BDD can support clients requiring integrated clinical testing and in vivo behavior investigation, ideal for companies advancing novel formulations.

Strategic Collaborations Recent partnerships, such as the joint development of levodopa formulations for Parkinson's and IBD-targeted tablets, highlight BDD’s potential as a reliable partner for biotech and pharma firms seeking customized drug delivery systems.

Technology-Driven Approach Utilizing advanced research tools like gamma scintigraphy and pharmacokinetic analysis, BDD offers unique insights into formulation performance, which can appeal to clients interested in demonstrating efficacy and safety for new drug products.

Growing Market Presence With recent funding of $1.6M and a revenue range of up to $10M, BDD is positioned for growth and expansion, providing opportunities for sales teams to target mid-sized pharmaceutical firms seeking innovative delivery technologies to enhance their product pipelines.

Similar companies to BDD

BDD Tech Stack

BDD uses 8 technology products and services including Microsoft Clarity, Open Graph, RSS, and more. Explore BDD's tech stack below.

  • Microsoft Clarity
    Analytics
  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • TweenMax
    Javascript Frameworks
  • Yoast SEO
    Search Engines
  • YouTube
    Video Players
  • jQuery Waypoints
    Web Tools And Plugins

Media & News

BDD's Email Address Formats

BDD uses at least 1 format(s):
BDD Email FormatsExamplePercentage
First.Last@bddpharma.comJohn.Doe@bddpharma.com
48%
FirstLas@bddpharma.comJohnDoe@bddpharma.com
2%
First.Last@bddpharma.comJohn.Doe@bddpharma.com
48%
FirstLas@bddpharma.comJohnDoe@bddpharma.com
2%

Frequently Asked Questions

Where is BDD's headquarters located?

Minus sign iconPlus sign icon
BDD's main headquarters is located at 84 Castle Street Glasgow, Scotland g4 0sf United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is BDD's stock symbol?

Minus sign iconPlus sign icon
BDD is a publicly traded company; the company's stock symbol is NBDD.L.

What is BDD's official website and social media links?

Minus sign iconPlus sign icon
BDD's official website is bddpharma.com and has social profiles on LinkedInCrunchbase.

What is BDD's NAICS code?

Minus sign iconPlus sign icon
BDD's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does BDD have currently?

Minus sign iconPlus sign icon
As of March 2026, BDD has approximately 54 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: C. T.Cro Manager: A. M.Chief Operating Officer: L. G.. Explore BDD's employee directory with LeadIQ.

What industry does BDD belong to?

Minus sign iconPlus sign icon
BDD operates in the Pharmaceutical Manufacturing industry.

What technology does BDD use?

Minus sign iconPlus sign icon
BDD's tech stack includes Microsoft ClarityOpen GraphRSSGoogle CloudTweenMaxYoast SEOYouTubejQuery Waypoints.

What is BDD's email format?

Minus sign iconPlus sign icon
BDD's email format typically follows the pattern of First.Last@bddpharma.com. Find more BDD email formats with LeadIQ.

How much funding has BDD raised to date?

Minus sign iconPlus sign icon
As of March 2026, BDD has raised $1.6M in funding. The last funding round occurred on Jan 01, 2021 for $1.6M.

When was BDD founded?

Minus sign iconPlus sign icon
BDD was founded in 1999.

BDD

Pharmaceutical ManufacturingScotland, United Kingdom51-200 Employees

BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products.

Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success.

Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers.

Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time.

Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. 

We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.

Section iconCompany Overview

Headquarters
84 Castle Street Glasgow, Scotland g4 0sf United Kingdom
Stock Symbol
NBDD.L
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1999
Employees
51-200

Section iconFunding & Financials

  • $1.6M

    BDD has raised a total of $1.6M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2021 in the amount of $1.6Mas a funding.

  • $1M$10M

    BDD's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1.6M

    BDD has raised a total of $1.6M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2021 in the amount of $1.6Mas a funding.

  • $1M$10M

    BDD's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.